We are live on ! Find out more
KOC

Koss-Olinger Consulting Portfolio holdings

AUM $1.19B
1-Year Est. Return 15.91%
This Fund
S&P 500
This Quarter Est. Return
-4.11%
1 Year Est. Return
+15.91%
3 Year Est. Return
+50.95%
5 Year Est. Return
+57.89%
10 Year Est. Return
AUM
$621M
AUM Growth
-$27.4M
Cap. Flow
-$1.29M
Cap. Flow %
-0.21%
Top 10 Hldgs %
72.17%
Holding
240
New
25
Increased
98
Reduced
70
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.33%
3 Communication Services 1.92%
4 Financials 1.59%
5 Consumer Staples 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPP icon
126
WPP
WPP
$4.36B
$398K 0.06%
6,081
-1,911
-24% -$142K
INGR icon
127
Ingredion
INGR
$6.27B
$397K 0.06%
4,551
-1,563
-26% -$141K
HYLB icon
128
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.52B
$381K 0.06%
10,093
+645
+7% +$24.7K
VGT icon
129
Vanguard Information Technology ETF
VGT
$139B
$380K 0.06%
7,304
+32
+0.4% +$1.64K
UNH icon
130
UnitedHealth
UNH
$376B
$376K 0.06%
737
-303
-29% -$146K
PYPL icon
131
PayPal
PYPL
$48.9B
$374K 0.06%
3,237
-116
-3% -$15.4K
CTXS
132
DELISTED
Citrix Systems Inc
CTXS
$370K 0.06%
3,663
+515
+16% +$52K
CVX icon
133
Chevron
CVX
$392B
$365K 0.06%
2,244
-640
-22% -$91.8K
TXG icon
134
10x Genomics
TXG
$6B
$362K 0.06%
4,763
AGG icon
135
iShares Core US Aggregate Bond ETF
AGG
$137B
$353K 0.06%
3,300
-3,127
-49% -$344K
AOR icon
136
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$350K 0.06%
6,489
-839
-11% -$45.7K
TMO icon
137
Thermo Fisher Scientific
TMO
$213B
$350K 0.06%
593
-101
-15% -$58K
VEA icon
138
Vanguard FTSE Developed Markets ETF
VEA
$229B
$347K 0.06%
7,220
+623
+9% +$30.3K
ABT icon
139
Abbott
ABT
$183B
$337K 0.05%
2,851
-520
-15% -$64.5K
PPC icon
140
Pilgrim's Pride
PPC
$6.51B
$332K 0.05%
13,235
-5,455
-29% -$142K
CNC icon
141
Centene
CNC
$30.7B
$327K 0.05%
3,879
+16
+0.4% +$1.31K
ABEV icon
142
Ambev
ABEV
$48.1B
$322K 0.05%
99,765
-42,390
-30% -$118K
PFE icon
143
Pfizer
PFE
$143B
$321K 0.05%
6,194
-1,680
-21% -$87.2K
AZN icon
144
AstraZeneca
AZN
$263B
$320K 0.05%
2,409
-1,318
-35% -$158K
GSK icon
145
GSK
GSK
$104B
$318K 0.05%
5,839
+193
+3% +$10.5K
LLY icon
146
Eli Lilly
LLY
$1.02T
$318K 0.05%
1,109
-787
-42% -$203K
TEF
147
DELISTED
Telefonica
TEF
$317K 0.05%
68,195
-21,132
-24% -$94.1K
EBAY icon
148
eBay
EBAY
$50.6B
$315K 0.05%
5,498
+1,998
+57% +$116K
MDT icon
149
Medtronic
MDT
$109B
$314K 0.05%
2,833
+424
+18% +$44.8K
SCHO icon
150
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$300K 0.05%
+12,096
New +$304K

Similar funds

Koss-Olinger Consulting's Q1 2022 Portfolio in Review

As of Q1 2022, Koss-Olinger Consulting held 240 positions worth $621M, down 4.2% from $649M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Koss-Olinger Consulting's Q1 2022 filing shows 25 new, 98 increased, 70 reduced and 34 closed positions. Its largest new stake was Pacer Trendpilot US Large Cap ETF: 1,049,420 shares worth $40.8M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.6M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.7% a quarter earlier, followed by Technology and Communication Services.

  • Koss-Olinger Consulting's largest Q1 2022 buy was Pacer Trendpilot US Large Cap ETF: 1,049,420 shares worth $40.8M.
  • Koss-Olinger Consulting added most to Schwab US Large- Cap ETF in Q1 2022, an estimated $6.63M increase.
  • Koss-Olinger Consulting's biggest Q1 2022 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.6M.
  • Koss-Olinger Consulting fully exited WisdomTree Dynamic International Equity Fund in Q1 2022, selling an estimated $21.1M.
  • Koss-Olinger Consulting's ten largest holdings make up 72% of its $621M portfolio in Q1 2022.
  • Koss-Olinger Consulting opened 25 new positions and closed 34 in Q1 2022.
  • Koss-Olinger Consulting's portfolio value fell 4.2% quarter-over-quarter to $621M.

Based on Koss-Olinger Consulting's 13F filing for Q1 2022, filed 6 May 2022.